Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024
... growth prospects across the Secondary Progressive Multiple Sclerosis (SPMS) market. A detailed picture of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline landscape is provided, which includes the disease overview and Secondary Progressive Multiple Sclerosis (SPMS) ... Read More
-
Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024
... the Chronic Progressive Multiple Sclerosis market. A detailed picture of the Chronic Progressive Multiple Sclerosis pipeline landscape is provided, which includes the disease overview and Chronic Progressive Multiple Sclerosis treatment guidelines. The assessment part of ... Read More
-
Multiple sclerosis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024
... the Relapsing Multiple Sclerosis (RMS) market. A detailed picture of the Relapsing Multiple Sclerosis (RMS) pipeline landscape is provided, which includes the disease overview and Relapsing Multiple Sclerosis (RMS) treatment guidelines. The assessment part of ... Read More
-
Injectable Cytotoxic Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 18.29 billion in 2023, and the market is now projected to grow from USD 19.03 billion in 2024 to USD 30.85 billion by 2032, exhibiting a CAGR of 6.2% during the forecast ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Anti-inflammatory Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Corticosteroids, Biologics), By Indication (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Anti-inflammatory Therapeutics market size is poised to register 6.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Central Nervous System Disorders Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Depression Drugs, Multiple Sclerosis Drugs, Schizophrenia Drugs, Bipolar Disorder Therapeutics, Epilepsy Drugs, Others), By Drug Class (Analgesics, Antidepressant, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Central Nervous System Disorders Therapeutics market size is poised to register 6.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Spasticity Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... studied was anticipated to grow with a CAGR of nearly 10.1% during the forecast period. The major factors attributing to the growth of the market are a rise in prevalence of multiple sclerosis, cerebral palsy, ... Read More
-
Continence Care Market Size, Trends, Analysis, and Outlook By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), by Region, Country, Segment, and Companies, 2024-2030
... Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Continence Care market size is poised to register 5.61% growth ... Read More
-
Multiple Sclerosis Therapeutics Market Size, Trends, Analysis, and Outlook By Drug (Large-molecule Drugs, Small-molecule Drugs), By Route of Administration (Oral, Injectable, Others), by Region, Country, Segment, and Companies, 2024-2030
... size is poised to register 6.4% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Multiple Sclerosis Therapeutics market across By Drug (Large-molecule ... Read More
-
Specialty Generics Market Size, Trends, Analysis, and Outlook By Type (Injectables, Oral drugs, Others), By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others), By End-user (Specialty pharmacy, Retail pharmacy, Hospital pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Specialty Generics market size is poised to register 11.48% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Magnetoencephalography Market Size, Trends, Analysis, and Outlook By Application (Clinical (Dementia, Autism, Schizophrenia,-Multiple Sclerosis, Stroke, Epilepsy), Research), By End-user (Hospitals, Imaging centers, Academic and research institutes), by Region, Country, Segment, and Companies, 2024-2030
... Magnetoencephalography market size is poised to register 4.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Magnetoencephalography market across By Application (Clinical ... Read More
-
Neurorehabilitation Devices Market Size, Trends, Analysis, and Outlook By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Neurorehabilitation Devices market size is poised to register 12.13% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurorehabilitation Devices ... Read More
-
Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030
... diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurological Biomarkers market size is poised to register 14.63% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Active Wheelchair Market Size, Trends, Analysis, and Outlook By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030
... Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Active Wheelchair market size is poised to register 5.04% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
2024 Global Forecast for Multiple Sclerosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Immunoassay for Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics, Research), By Region and Competition
... By Region and Competition Global Immunoassay for Neurological Biomarkers Market was valued at USD 624.22 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 17.22% through ... Read More
-
Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029
... billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The COVID-19 pandemic significantly impacted the healthcare systems, affecting not only patients infected with COVID-19 but also others, resulting in disruptions ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market Growth 2024-2030
... downstream market, the Multiple Sclerosis (MS) Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
Research Assistance
